Clinical Trial Update: A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy, safety, and tolerability of IRL201104 in adults with active eosinophilic esophagitis has completed, and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• IRL201104

Snippet

Sponsor: Revolo Biotherapeutics | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED | Results posted: 2025-05-21